跳至主要内容
临床试验/IRCT2015121725574N1
IRCT2015121725574N1已完成2 期

Double-blind clinical study of the therapeutic effects of pomegranate juice powder on renal damage in diabetic nephropathy.

Shiraz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • inclusion criteria: patients 20 to 75 years old receiving reducer blood glucose drug and dietary recommendations for at least 6 month with type II diabetes. That the urine microalbumin and the amount of protein in urine 24 hours higher than normal and receive a fixed dose of either or both ACEI or ARB at least 3 months. Exclusion criteria: certain underlying diseases such as autoimmune diseases or cancer, allergies to plants used in the clinical trial, pregnancy and breastfeeding, dialysis.

排除标准

  • 未提供

研究者

相似试验